Abstract
Context: Fatty pancreas is associated with obesity and metabolic alterations and may coexist with pancreatic structural remodeling. However, its contribution to β-cell dysfunction remains unclear. Objective: We investigated the relationship between pancreatic fat, tissue remodeling, and β-cell function. Design: We conducted a cross-sectional study in individuals with ultrasound-detected pancreatic hyperechogenicity without prior diagnosis of diabetes. Pancreatic fat was quantified by magnetic resonance imaging (MRI)-derived proton density fat fraction, while tissue stiffness was assessed by shear wave elastography. Metabolic phenotyping was based on oral glucose tolerance test (OGTT). Participants: We recruited 29 individuals with ultrasound-detected fatty pancreas (F/M 16/13, age 54 ± 10.4 years) and assessed glucose tolerance with OGTT: 75.9% exhibited normal glucose tolerance (n = 22), while 24.1% had impaired glucose tolerance (n = 7). Results: MRI-derived pancreatic fat fraction was positively correlated with anthropometric measures (body mass index ρ = 0.43, P = .02) and β-cell function (β-cell glucose sensitivity ρ = 0.40, P = .03). Pancreatic stiffness correlated negatively with body weight (ρ = −0.38, P = .04), did not correlate with pancreatic fat fraction (ρ = −0.15, P = .44), and was correlated inversely with the potentiation factor ratio 1 (ρ = −0.44, P = .02), a measure of non–glucose-dependent amplification of insulin secretion. Conclusion: Intrapancreatic fat and pancreatic stiffness appear to reflect distinct pathophysiological processes, with potentially different relationships to systemic metabolic status and β-cell function. These findings support a more nuanced view of pancreatic structural alterations as heterogeneous markers of metabolic dysfunction.

This publication has 42 references indexed in Scilit: